
Glimnox MP 2mg/500mg/15mg Tablet SR
Marketer
Noxin Biocare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimnox MP 2mg/500mg/15mg Tablet SR
Diabex Trio 2mg/500mg/15mg Extended-Release Tablets combine medications to effectively manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin efficiency, reducing blood sugar. Always adhere to your physician's prescribed dosage and duration for Diabex Trio 2mg/500mg/15mg Extended-Release Tablets; take with food to prevent gastric distress. If a dose is missed, take it promptly unless the next dose is imminent; then, omit the missed dose and resume your regular schedule. Never double the dose. Excessive intake can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood sugar monitoring is essential. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical advice before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption during treatment to minimize potential side effects.
Primary Ingredients of Glimnox MP 2mg/500mg/15mg Tablet SR
The provided text is "undefined," which lacks meaning and cannot be rephrased. A rephrased version is therefore impossible.
Uses of Glimnox MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimnox MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimnox MP 2mg/500mg/15mg Tablet SR whole; do not damage or alter its form. It should be administered with a meal.
Common Side effects of Glimnox MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimnox MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimnox MP 2mg/500mg/15mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with food.
How Glimnox MP 2mg/500mg/15mg Tablet SR works:
Glimnox MP 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach offers enhanced blood glucose management when single or dual therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimnox MP 2mg/500mg/15mg SR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimnox MP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimnox MP 2mg/500mg/15mg tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, possibly harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimnox MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glimnox MP 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimnox MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimnox MP 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimnox MP 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Glimnox MP 2mg/500mg/15mg Tablet SR, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Glimnox MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
